Karen Cox Selected Research

Karen Cox Research Topics

Disease

12	Neoplasms (Cancer) 03/2020 - 01/2002
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 09/2008
3	Inflammation (Inflammations) 01/2017 - 03/2008
2	Urinary Incontinence 11/2018 - 03/2012
2	Infections 01/2017 - 01/2016
2	Death (Near-Death Experience) 03/2016 - 11/2007
2	Lung Neoplasms (Lung Cancer) 04/2014 - 05/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2003 - 10/2002
1	Crohn Disease (Crohn's Disease) 01/2021
1	Necrosis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Breast Neoplasms (Breast Cancer) 03/2020
1	Colonic Neoplasms (Colon Cancer) 04/2014
1	Frailty 09/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Atherosclerosis 03/2008
1	Atherosclerotic Plaque (Atheroma) 03/2008
1	Disease Progression 03/2008
1	Body Weight (Weight, Body) 09/2007
1	Drug-Related Side Effects and Adverse Reactions 01/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2003
1	Carcinoma (Carcinomatosis) 04/2003
1	Stomach Neoplasms (Stomach Cancer) 04/2003
1	Prostatic Neoplasms (Prostate Cancer) 02/2003
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 03/2008 - 01/2002
3	CytokinesIBA 01/2021 - 10/2002
3	AntibodiesIBA 01/2017 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007 - 10/2002
2	Gemcitabine FDA Link 04/2014 - 10/2002
2	ElementsIBA 09/2008 - 09/2007
2	Biomarkers (Surrogate Marker)IBA 03/2008 - 04/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2007 - 04/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2003 - 10/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2003 - 10/2002
1	apremilastIBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	Phosphodiesterase 4 InhibitorsIBA 01/2021
1	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 03/2020
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 04/2014
1	Checkpoint Kinase 1IBA 04/2014
1	LY2603618IBA 04/2014
1	Indicators and Reagents (Reagents)IBA 09/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	CholesterolIBA 03/2008
1	RNA (Ribonucleic Acid)IBA 03/2008
1	Blood Proteins (Serum Proteins)IBA 03/2008
1	Ramipril (Altace)FDA LinkGeneric 03/2008
1	Simvastatin (Zocor)FDA LinkGeneric 03/2008
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2007
1	Transaminases (Aminotransferases)IBA 09/2007
1	Cyclin D1IBA 09/2007
1	Eukaryotic Initiation Factor-4EIBA 09/2007
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2006
1	liposomal doxorubicin (Doxil)FDA Link 01/2006
1	Liposomes (Liposome)IBA 01/2006
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 02/2003
1	Protein Kinases (Protein Kinase)IBA 10/2002
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2002
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2002
1	Carboplatin (JM8)FDA LinkGeneric 10/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2003
3	Drug Therapy (Chemotherapy) 03/2008 - 10/2002
2	Aftercare (After-Treatment) 03/2020 - 05/2006
2	Nursing Care 11/2018 - 03/2012
2	Palliative Care (Palliative Therapy) 03/2016 - 09/2012
1	Stem Cell Transplantation 03/2010
1	Resuscitation 11/2007